NASDAQ: OBIO
Orchestra Biomed Holdings Inc Stock Ownership - Who owns Orchestra Biomed Holdings?

Insider buying vs selling

Have Orchestra Biomed Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chris ClearyDirector2026-02-05676$3.71
$2.51kSell
Darren ShermanPresident and Chief Operating Officer2026-01-025,588$4.31
$24.08kSell
Andrew Lawrence TaylorChief Financial Officer2026-01-023,452$4.31
$14.88kSell
Joshua AielloPrincipal Accounting Officer2026-01-02241$4.31
$1.04kSell
David P. HochmanChief Executive Officer and Chairperson2025-12-1040,355$4.67
$188.46kSell
Andrew Lawrence TaylorChief Financial Officer2025-12-108,670$4.67
$40.49kSell
David P. HochmanChief Executive Officer and Chairperson2025-12-103,283$4.67
$15.33kSell
Darren ShermanPresident and Chief Operating Officer2025-11-2540,340$5.35
$215.82kSell
Andrew Lawrence TaylorChief Financial Officer2025-11-253,071$5.35
$16.43kSell
David P. HochmanChief Executive Officer and Chairperson2025-11-145,000$4.07
$20.35kBuy

1 of 4

OBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OBIO insiders and whales buy or sell their stock.

OBIO Shareholders

What type of owners hold Orchestra Biomed Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP23.80%13,926,708$58.49MInsider
Rtw Investments LP14.19%8,306,063$34.89MInstitution
Medtronic PLC10.03%5,868,916$24.65MInsider
Perceptive Advisors LLC9.04%5,292,556$22.23MInsider
Perceptive Advisors LLC8.76%5,127,256$21.53MInstitution
Roderick Wong4.80%2,808,512$11.80MInsider
Geoffrey Wade Smith3.17%1,855,696$7.79MInsider
Hsac 2 Holdings LLC2.91%1,705,705$7.16MInsider
Vanguard Group Inc2.74%1,604,556$6.74MInstitution
David P. Hochman2.61%1,525,089$6.41MInsider

1 of 3

OBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OBIO37.08%61.37%Net BuyingNet Selling
CHRS34.23%14.29%Net SellingNet Selling
CLLS14.58%0.00%
ALDX64.69%27.76%Net Selling
RZLT45.59%54.41%Net BuyingNet Selling

Orchestra Biomed Holdings Stock Ownership FAQ

Who owns Orchestra Biomed Holdings?

Orchestra Biomed Holdings (NASDAQ: OBIO) is owned by 37.08% institutional shareholders, 61.37% Orchestra Biomed Holdings insiders, and 1.55% retail investors. Rtw Investments LP is the largest individual Orchestra Biomed Holdings shareholder, owning 13.93M shares representing 23.80% of the company. Rtw Investments LP's Orchestra Biomed Holdings shares are currently valued at $58.49M.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.